Dodge & Cox Portfolio holdings
Dodge & Cox, founded in 1930 by Van Duyn Dodge and E. Morris Cox in San Francisco, California, is an independent, employee-owned investment management firm renowned for its disciplined, value-oriented approach to long-term investing. Managing over $350 billion in assets as of late 2024, the firm offers a concise lineup of mutual funds and separate accounts focusing on U.S. and international equities, fixed income, and balanced portfolios, serving individual and institutional investors with a low-turnover, research-driven strategy. Known for its team-based decision-making and contrarian stance—buying undervalued securities others overlook—Dodge & Cox has maintained a consistent philosophy through decades, avoiding trend-chasing and emphasizing fundamentals, even during market volatility like the 2008 crisis. With a tight-knit team of about 300 employees and no proprietary trading, the firm’s commitment to simplicity, low fees, and client alignment has earned it a loyal following and a reputation as a steadfast player in asset management.
Top Buys
| 1 |
CVS Health
CVS
|
$747M |
| 2 |
Bank of America
BAC
|
$668M |
| 3 |
Truist Financial
TFC
|
$648M |
| 4 |
VF Corp
VFC
|
$567M |
| 5 |
Fidelity National Information Services
FIS
|
$491M |
Top Sells
| 1 |
VMW
VMware, Inc
VMW
|
$1.05B |
| 2 |
Alphabet (Google) Class C
GOOG
|
$644M |
| 3 |
Capital One
COF
|
$613M |
| 4 |
Cisco
CSCO
|
$608M |
| 5 |
UBS Group
UBS
|
$455M |
Sector Composition
| 1 | Financials | 20.65% |
| 2 | Healthcare | 19.58% |
| 3 | Technology | 15.74% |
| 4 | Communication Services | 12.93% |
| 5 | Industrials | 9.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Berkshire Hathaway Class B
BRK.B
$1.09T
| $4.49M | ﹤0.01% |
12,820
| – | – |
|
127
Danaher
DHR
$147B
| $4.2M | ﹤0.01% |
16,925
| – | – |
|
128
Apple
AAPL
$3.45T
| $4.19M | ﹤0.01% |
24,456
-200
| -0.8% | -$34.2K |
|
129
APA Corp
APA
$8.31B
| $4.03M | ﹤0.01% |
98,050
-18,100
| -16% | -$744K |
|
130
Pfizer
PFE
$141B
| $3.93M | ﹤0.01% |
118,485
-4,500
| -4% | -$149K |
|
131
Amgen
AMGN
$155B
| $3.87M | ﹤0.01% |
14,382
-100
| -0.7% | -$26.9K |
|
132
Shell
SHEL
$215B
| $3.86M | ﹤0.01% |
60,013
-200
| -0.3% | -$12.9K |
|
133
Johnson & Johnson
JNJ
$427B
| $3.29M | ﹤0.01% |
21,097
-300
| -1% | -$46.7K |
|
134
Cemex
CX
$13.2B
| $3.23M | ﹤0.01% |
496,500
+7,200
| +1% | +$46.8K |
|
135
Corning
GLW
$57.4B
| $2.83M | ﹤0.01% |
92,942
-1,700
| -2% | -$51.8K |
|
136
Motorola Solutions
MSI
$78.7B
| $2.35M | ﹤0.01% |
8,627
| – | – |
|
|
137
Berkshire Hathaway Class A
BRK.A
$1.09T
| $2.13M | ﹤0.01% |
4
| – | – |
|
138
Diageo
DEO
$62.1B
| $2.08M | ﹤0.01% |
13,911
| – | – |
|
139
S&P Global
SPGI
$167B
| $1.97M | ﹤0.01% |
5,400
-200
| -4% | -$73.1K |
|
140
McDonald's
MCD
$224B
| $1.84M | ﹤0.01% |
7,000
-100
| -1% | -$26.3K |
|
141
PNC Financial Services
PNC
$81.7B
| $1.75M | ﹤0.01% |
14,275
| – | – |
|
142
Abbott
ABT
$231B
| $1.73M | ﹤0.01% |
17,857
| – | – |
|
143
AbbVie
ABBV
$372B
| $1.67M | ﹤0.01% |
11,176
-34
| -0.3% | -$5.07K |
|
144
Philip Morris
PM
$260B
| $1.57M | ﹤0.01% |
17,000
| – | – |
|
145
Honeywell
HON
$139B
| $1.48M | ﹤0.01% |
8,019
| – | – |
|
146
Las Vegas Sands
LVS
$39.6B
| $1.44M | ﹤0.01% |
31,500
+2,600
| +9% | +$119K |
|
147
DuPont de Nemours
DD
$32.2B
| $1.38M | ﹤0.01% |
18,567
-150
| -0.8% | -$11.2K |
|
148
Coca-Cola
KO
$297B
| $1.38M | ﹤0.01% |
24,635
| – | – |
|
149
NextEra Energy, Inc.
NEE
$148B
| $1.37M | ﹤0.01% |
24,000
| – | – |
|
150
Corteva
CTVA
$50.4B
| $1.37M | ﹤0.01% |
26,813
-80
| -0.3% | -$4.09K |
|